Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX®

Journal of Rheumatology

Volumn 37, Issue 11, 2010, Pages 2221-2225

  Cheng, Carly K ^a,b   McDonald Blumer, Heather ^b,c   Boire, Gilles ^d   Pope, Janet E ^e   Haraoui, Boulos ^f   Hitchon, Carol A ^g   Thorne, Carter ^h   Sun, Ye ^c   Bykerk, Vivian P ^b,i  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e WESTERN UNIVERSITY   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

ⁱ HARVARD UNIVERSITY   (United States)

Author keywords

Bone fractures; Osteoporosis; Rheumatoid arthritis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; PREDNISONE; VITAMIN D;

ADULT; AGED; ARTHRITIS; ARTICLE; BONE DENSITY; CALCIUM INTAKE; CANADA; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; FEMALE; FRACTURE RISK ASSESSMENT TOOL; FRAGILITY FRACTURE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; VITAMIN INTAKE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTHRITIS; BODY WEIGHT; BONE DENSITY; CANADA; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 78149243946     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.091368     Document Type: Article

References (18)

1. Hooyman JR, Melton LJ 3rd, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 1984;27:1353-61.
2. Haugeberg G, Conaghan PG, Quinn M, Emery P. Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomized, double blind, placebo-controlled study. Ann Rheum Dis 2009;68:1898-901.
3. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
4. Virtama P, Helella T, Kalliomaka JL. Osteoporosis in rheumatoid arthritis: a follow up study. Acta Rheumatol Scand 1968;14:276-84.
5. Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, et al. The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporosis Int 2008;19:581-7.
6. Ursum J, Britsemmer K, van Schaardenburg D, Lips PT, Dijkmans BA, Lems W. High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis. Ann Rheum Dis 2009;68:1512-3.
7. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7.
8. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E. Economic implications of hip fracture: Health service use, institutional care and cost in Canada. Osteoporos Int 2001;12:271-8.
9. Richards JS, Peng J, Amdur RL, Mikuls TR, Hooker RS, Michaud K, et al. Dual-energy x-ray absorptiometry and evaluation of the Osteoporosis Self-Assessment Tool in men with rheumatoid arthritis. J Clin Densitom 2009;12:434-40.
10. Brand C, Lowe A, Hall S. The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis. BMC Musculoskel Disord 2008;9:13.
11. Kanis JA, Johnell O, Oden A, Johansson H. FRAXTM assessment of fracture probability in men and women from the UK. Osteoporosis Int 2008;19:385-97.
12. Shields M, Gorber SC, Tremblay MS. Estimates of obesity based on self-report versus direct measures. Statistics Canada Health Reports. Vol 19, No. 2, June 2008. Ottawa: Statistics Canada; 2008.
13. Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167 Suppl 10:S1-34.
14. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11:83-91.
15. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008;59:807-15.
16. Christodoulou C, Cooper C. What is osteoporosis? Postgrad Med J 2003;79:133-8.
17. Fardellone P. Predicting the fracture risk in 2008. Joint Bone Spine 2008;75:661-4.
18. Curtis JR, Arora T, Donaldson M, Alarcón GS, Callahan LF, Moreland LW, et al. Skeletal health among African Americans with recent-onset rheumatoid arthritis. Arthritis Rheum 2009;61:1379-86.